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Themacrocyclic polyketide tacrolimus (FK506) is a potent immunosuppressant that prevents T-cell proliferation produced
solely by Streptomyces species. We report here the first draft genome sequence of a true FK506 producer, Streptomyces tsukubae-
nsisNRRL 18488, the first tacrolimus-producing strain that was isolated and that contains the full tacrolimus biosynthesis gene
cluster.
The genus Streptomyces includes high GCGram-positive bac-teria, which present a characteristic life cycle closely connected
with their ability to produce secondarymetabolites (5). These bac-
teria are among the most ubiquitous soil microorganisms (1).
Streptomyces tsukubaensis was isolated in 1984 from a soil sample
obtained from the Tsukuba region of Japan, and it became rele-
vant due to its ability to produce the potent immunosuppressant
agent tacrolimus (FK506) (3), which is a commercially available
and clinically used anti-allograft rejection drug. Initially, it was
deposited as strain no. 9993, and later it was redeposited in the
ARS culture collection under the accession number NRRL 18488.
Tacrolimus yielded $2,340 million in profits in 2011 (http://www
.evaluatepharma.com).
Genomic DNA from S. tsukubaensis NRRL 18488 was ex-
tracted according to the Kirby method (2) from a 60-h culture
(stationary phase) in order to avoid bias in the distribution of
reads through the chromosome due to its replication. The se-
quencing processwas done bymeans of a 3-kbppaired-end library
on the GS FLX sequencer (Roche). Two runs were carried out that
yielded 158.8 and 153.4 Mbp. Gap closure was performed by
means of a 1/4 plate shotgun Titanium 454 sequencing round
(Roche), which yielded 86.0 Mbp of DNA sequence. In total, it
gives a 52 genome final coverage. Reads were assembled using
the Newbler Assembler software (version 2.3; Roche) into 14 scaf-
folds. Amanual validationwas carried out for specific genes (e.g., the
tacrolimus gene cluster) and repetitive regions (e.g., rRNAs) using
DNA sequences fromanordered cosmid library of S. tsukubaensis, as
described by Martínez-Castro and coworkers for Streptomyces
tacrolimicus (4).Thus, afinalunique linear chromosomeof7.62Mbp
(71.52% GC content), which is within the size range reported for
other streptomycetes, and two circular plasmids, pSTS1 and pSTS2,
of 24.7 (70.04% GC) and 31.1 (71.13% GC) kbp, respectively,
were obtained. In addition, the 5=-telomerewas definedby rapid am-
plification of cDNA ends (RACE) methodology and showed a con-
formation similar to that of other Streptomyces species (7) but with a
more robust seven-hairpin structure. Genome annotation was per-
formed at the NCBI Prokaryotic Genomes Automatic Annotation
Pipeline (PGAAP) (http://www.ncbi.nlm.nih.gov/genomes/static
/Pipeline.html), with the identification of 6,623 protein-coding
genes, 6 rRNA operons (18 genes), 68 tRNAs, and 52 sigma factors.
The genome mining showed, in addition to the tacrolimus
gene cluster that is fully sequenced and publicly available for the
first time, several secondary metabolite gene clusters, including
four type I PKS (polyketide synthase), two type II PKS, one type III
PKS, three NRPS (non ribosomal peptide synthetase), three hy-
brid PKS/NRPS, eight terpene, six lantibiotic, and three sidero-
phore gene clusters. They were identified and annotated bymeans
of antiSMASH and NRPSsp servers (6, 8). This vast arsenal of
secondary metabolite genes points to S. tsukubaensis as a highly
profitable industrial microorganism, even beyond its use in ta-
crolimus production.
Nucleotide sequence accessionnumbers.ThisWholeGenome
Shotgun project (chromosome and both plasmids) has been depos-
ited at DDBJ/EMBL/GenBank under the accession number
AJSZ00000000.Theversiondescribed in thispaper is thefirst version,
AJSZ01000000.
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